| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |